{
  "created_at": "Fri Jul 09 22:24:6 +0000 2021",
  "id_str": "1413544661239615490",
  "full_text": "The FDA has asked for a federal investigation of its own doctors who met with the makers of an Alzheimer's drug prior to its approval https://t.co/nmMzsoD7EF",
  "display_text_range": [
    0,
    157
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/nmMzsoD7EF",
        "expanded_url": "https://on.wsj.com/36nK4jB",
        "display_url": "on.wsj.com/36nK4jB",
        "indices": [
          134,
          157
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 34,
  "favorite_count": 83,
  "possibly_sensitive": false,
  "original_created_at": "Fri Jul 09 17:04:44 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDAは、アルツハイマー型認知症治療薬の承認前にメーカーと面会した自社の医師について、連邦政府に調査を要請した https://t.co/nmMzsoD7EF"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局要求对自己的医生进行联邦调查，这些医生在批准一种阿尔茨海默氏症药物之前与制造商进行了会面https://t.co/nmMzsoD7EF。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局要求對自己的醫生進行聯邦調查，這些醫生在批准一種阿爾茨海默氏症藥物之前與製造商進行了會面https://t.co/nmMzsoD7EF。"
    }
  ]
}